Benitec Biopharma Limited (BNTC) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the ...

Revenue: US$18.5m (up 2.6% from 3Q 2024). Net income: US$3.94m (up from US$2.89m loss in 3Q 2024). Profit margin: 21% (up from net loss in 3Q 2024). EPS: US$0.64 (up from US$0.52 loss in 3Q 2024 ...

Mr. David Weild is an Independent Director at High Roller Technologies, Inc., a Chairman at The INX Digital Co., Inc., an Independent Director at Scopus Biopharma, Inc., an Independent Director at ...

Although East Asians make up a significant share of entry-level roles in U.S. biopharma, few have risen to senior leadership positions. That disparity is what inspired the launch of ElevAAte—a ...

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing ...

Bionic Biologics provide a new approach to targeting protein-protein interactions (PPI), distinguished by the following key characteristics: Grove Biopharma’s Bionic Biologics have been ...

Q1 biopharma layoff trends, plus expectations for Q2 By Ayla Ellison, Gabrielle Masson, Andrea Park Apr 11, 2025 9:25am The Top Line layoffs Cell & Gene Therapy biopharma industry ...

BioPharma Credit (LSE: BPCR) is one of the more esoteric investment trusts listed in London. Biotech is a specialist sector that I usually wouldn’t touch with a barge pole. The risk of failure ...

CANF opened at $1.60 on Friday. Can-Fite BioPharma has a one year low of $1.29 and a one year high of $4.69. The company’s 50 day simple moving average is $1.59 and its 200-day simple moving ...

On Dec. 20, biopharmaceutical company Quantum BioPharma (QNTM) disclosed the purchase of $1 million worth of Bitcoin (BTC) and other cryptocurrencies. The company’s shares on the Nasdaq were ...